VIVS (VivoSim Labs, Inc. Common Stock) Stock Analysis - Insider Trades

VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of May 21, 2026, VIVS trades at $1.29 with a market cap of $3.68M and a P/E ratio of 0.00. VIVS moved +0.00% today. Year to date, VIVS is -33.33%; over the trailing twelve months it is -35.96%. Its 52-week range spans $1.25 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading VIVS stock inside the company?

Recent VIVS insider activity includes Gobel David bought 3.27K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

VIVS Key Metrics

Key financial metrics for VIVS
MetricValue
Price$1.29
Market Cap$3.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.30
52-Week Low$1.25
Volume177.55K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Recent VIVS Insider Trades

  • Gobel David bought 3.27K (~$7.30K) on Nov 17, 2025.

Latest VIVS News

VIVS Analyst Consensus

VIVS analyst coverage data. Average price target: $0.00.

Common questions about VIVS

Who is trading VIVS stock inside the company?
Recent VIVS insider activity includes Gobel David bought 3.27K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VIVS?
Yes. Rallies tracks VIVS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VIVS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VIVS. It does not provide personalized investment advice.
VIVS

VIVS